Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial by Shukuya, Takehito, MD, Yamanaka, Takeharu, Prof, Seto, Takashi, MD, Daga, Haruko, MD, Goto, Koichi, MD, Saka, Hideo, MD, Sugawara, Shunichi, MD, Takahashi, Toshiaki, MD, Yokota, Soichiro, MD, Kaneda, Hiroyasu, MD, Kawaguchi, Tomoya, MD, Nagase, Seisuke, MD, Oguri, Tetsuya, MD, Iwamoto, Yasuo, MD, Nishimura, Takashi, MD, Hattori, Yoshihiro, MD, Nakagawa, Kazuhiko, Prof, Nakanishi, Yoichi, Prof, Yamamoto, Nobuyuki, Dr Prof

Get full text